Anti-allergic effects of mapracorat, a novel selective glucocorticoid receptor agonist, in human conjunctival fbroblasts and epithelial cells

Molecular Vision

Volumn 19, Issue , 2013, Pages 1515-1525

  Cavet, Megan E ^a   Volhejn, Stepan ^a   Harrington, Karen L ^a   Zhang, Jin Zhong ^a  

^a BAUSCH AND LOMB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DEXAMETHASONE; EOTAXIN; EOTAXIN 3; GLUCOCORTICOID RECEPTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 13; INTERLEUKIN 4; MAPRACORAT; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ALLERGY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONJUNCTIVA; CONTROLLED STUDY; CYTOKINE RELEASE; EPITHELIUM CELL; FIBROBLAST; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTI-ALLERGIC AGENTS; ANTI-INFLAMMATORY AGENTS; BENZOFURANS; CATTLE; CONJUNCTIVA; EPITHELIAL CELLS; FIBROBLASTS; GENE SILENCING; HUMANS; HYPERSENSITIVITY; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-13; INTERLEUKIN-4; PENTANOLS; QUINOLINES; RECEPTORS, GLUCOCORTICOID; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84880408425     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Ono SJ, Abelson MB. Allergic conjunctivitis: update on patho-physiology and prospects for future treatment. J Allergy Clin Immunol 2005; 115:118-122. [PMID:15637556].
2. Bielory BP, Perez VL, Bielory L. Treatment of seasonal allergic conjunctivitis with ophthalmic corticosteroids: in search of the perfect ocular corticosteroids in the treatment of allergic conjunctivitis. Curr Opin Allergy Clin Immunol 2010; 10:469-77.[PMID:20720489].
3. Offiah I, Calder VL. Immune mechanisms in allergic eye diseases: what is new? Curr Opin Allergy Clin Immunol 2009; 9:477-81.[PMID:19620858].
4. Bielory L. Ocular allergy overview. Immunol Allergy Clin North Am 2008; 28:1-23. v.[PMID: 18282543].
5. Macleod JD, Anderson DF, Baddeley SM, Holgate ST, McGill JI, Roche WR. Immunolocalization of cytokines to mast cells in normal and allergic conjunctiva. Clin Exp Allergy 1997; 27:1328-34. [PMID:9420138].
6. Anderson DF, Zhang S, Bradding P, McGill JI, Holgate ST, Roche WR. The relative contribution of mast cell subsets to conjunctival TH2-like cytokines. Invest Ophthalmol Vis Sci 2001; 42:995-1001 [PMID:11274077].
7. Cook EB, Stahl JL, Barney NP, Graziano FM. Olopatadine inhibits anti-immunoglobulin E-stimulated conjunctival mast cell upregulation of ICAM-1 expression on conjunc-tival epithelial cells. Ann Allergy Asthma Immunol 2001; 87:424 -429.[PMID:11730187].
8. Kumagai N, Fukuda K, Fujitsu Y, Yamamoto K, Nishida T. Role of structural cells of the cornea and conjunctiva in the pathogenesis of vernal keratoconjunctivitis. Prog Retin Eye Res 2006; 25:165-87.[PMID:16427347].
9. Cook EB, Stahl JL, Lowe L, Chen R, Morgan E, Wilson J, Varro R, Chan A, Graziano FM, Barney N P. Simultaneous measurement of six cytokines in a single sample of human tears using microparticle-based flow cytometry: allergics vs. non-allergics. J Immunol Methods 2001; 254:109-18.[PMID:114 0 6157].
10. Stern ME, Siemasko K, Gao J, Duong A, Beauregard C, Calder V, Niederkorn J Y. Role of interferon-gamma in a mouse model of allergic conjunctivitis. Invest Ophthalmol Vis Sci 2005; 46:3239-46.[PMID:16123425].
11. Leonardi A, Curnow SJ, Zhan H, Calder VL. Multiple cyto-kines in human tear specimens in seasonal and chronic allergic eye disease and in conjunctival fibroblast cultures. Clin Exp Allergy 2006; 36:777-84. [PMID:16776679].
12. Leonardi A, Jose PJ, Zhan H, Calder VL. Tear and mucuseotaxin-1 and eotaxin-2 in allergic keratoconjunctivitis. Ophthalmology 2003; 110:487-92. [PMID:12623809].
13. Stahl JL, Cook EB, Graziano FM, Barney N P. Differential and cooperative effects of TNFalpha, IL-1beta, and IFNgamma on human conjunctival epithelial cell receptor expression and chemokine release. Invest Ophthalmol Vis Sci 2003; 44:2010-5. [PMID:12714637].
14. Hingorani M, Calder VL, Buckley RJ, Lightman SL. The role of conjunctival epithelial cells in chronic ocular allergic disease. Exp Eye Res 1998; 67:491-500. [PMID:9878210].
15. Fukagawa K, Okada N, Fujishima H, Nakajima T, Takano Y, Tanaka M, Dogru M, Satake Y, Tsubota K, Saito H. Corneal and conjunctival fibroblasts are major sources of eosinophil-recruiting chemokines. Allergol Int 2009; 58:499-508.[PMID:19700933].
16. Enríquez-de-Salamanca A, Calder V, Gao J, Galatowicz G, Garcia-Vazquez C, Fernandez I, Stern ME, Diebold Y, Calonge M. Cytokine responses by conjunctival epithelial cells: an in vitro model of ocular inflammation. Cytokine 2008; 44:160-7. [PMID:18760 623].
17. De Bosscher K. Selective Glucocorticoid Receptor modula-tors. J Steroid Biochem Mol Biol 2010; 120:96-104. [PMID:20206690].
18. Stahn C, Lowenberg M, Hommes DW, Buttgereit F. Molec-ular mechanisms of glucocorticoid action and selective glucocor ticoid receptor agonists. Mol Cell Endocr inol 2007; 275:71-8. [PMID:1763 0118].
19. Löwenberg M, Stahn C, Hommes DW, Buttgereit F. Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligands. Steroids 2008; 73:1025-9. [PMID:182 21974].
20. Schäcke H, Berger M, Rehwinkel H, Asadullah K. Selective glucocorticoid receptor agonists (SEGRAs): novel ligands with an improved therapeutic index. Mol Cell Endocrinol 2007; 275:109-17. [PMID:1763 0119].
21. Schäcke H, Hennekes H, Schottelius A, Jaroch S, Lehmann M, Schmees N, Rehwinkel H, Asadullah K. SEGRAs: a novel class of anti-inflammatory compounds. Ernst Schering Res Found Workshop 2002; 40357-71. [PMID:12355726].
22. Pfeffer BA, DeWitt CA, Salvador-Silva M, Cavet ME, Lopez FJ, Ward KW. Reduced myocilin expression in cultured monkey trabecular meshwork cells induced by a selective glucocorticoid receptor agonist: comparison with steroids. Invest Ophthalmol Vis Sci 2010; 51:437-46. [PMID:19696178].
23. Shafiee A, Bucolo C, Budzynski E, Ward KW, Lopez FJ. In vivo ocular efficacy profile of mapracorat, a novel selective glucocorticoid receptor agonist, in rabbit models of ocular disease. Invest Ophthalmol Vis Sci 2011; 52:1422-30. [PMID:20881303].
24. Vignali DA. Multiplexed particle-based flow cytometric assays. J Immunol Methods 2000; 243:243-55. [PMID:10986418].
25. Morgan E, Varro R, Sepulveda H, Ember JA, Apgar J, Wilson J, Lowe L, Chen R, Shivraj L, Agadir A, Campos R, Ernst D, Gaur A. Cytometric bead array: a multiplexed assay platform with applications in various areas of biology. Clin Immunol 2004; 110:252-266. [PMID:15047203].
26. Baiula M, Sparta A, Bedini A, Carbonari G, Bucolo C, Ward KW, Zhang JZ, Govoni P, Spampinato S. Eosinophil as a cellular target of the ocular anti-allergic action of mapracorat, a novel selective glucocorticoid receptor agonist. Mol Vis 2011; 17:3208-3223. [PMID:22194647].
27. Zhang JZ, Cavet ME, VanderMeid KR, Salvador-Silva M, Lopez FJ, Ward KW. BOL-303242-X, a novel selective glucocorticoid receptor agonist, with full anti-inflammatory proper ties in human ocular cells. Mol Vis 2009; 15:2606-2616. [PMID:20011631].
28. Cavet ME, Harrington KL, Ward KW, Zhang JZ. Mapracorat, a novel selective glucocorticoid receptor agonist, inhibits hyperosmolar-induced cytokine release and MAPK pathways in human corneal epithelial cells. Mol Vis 2010; 16:1791-1800. [PMID:20824100].
29. Schäcke H, Zollner TM, Docke WD, Rehwinkel H, Jaroch S, Skuballa W, Neuhaus R, May E, Zugel U, Asadullah K. Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseases. Br J Pharmacol 2009; 158:1088-103. [PMID:19422381].
30. Beck IM, Vanden Berghe W, Vermeulen L, Yamamoto KR, Haegeman G, De Bosscher K. Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases. Endocr Rev 2009; 30:830-82. [PMID:19890091].
31. Hebenstreit D, Wirnsberger G, Horejs-Hoeck J, Duschl A. Signaling mechanisms, interaction partners, and target genes of STAT6. Cytokine Growth Factor Rev 2006; 17:173-88. [PMID:16540365].
32. Reber LL, Daubeuf F, Plantinga M, De Cauwer L, Gerlo S, Waelput W, Van Calenbergh S, Tavernier J, Haegeman G, Lambrecht BN, Frossard N, De Bosscher K. A dissociated glucocorticoid receptor modulator reduces airway hyperre-sponsiveness and inflammation in a mouse model of asthma. J Immunol 2012; 188:3478-87. [PMID:22393156].
33. Shoji J, Inada N, Sawa M. Evaluation of eotaxin-1, -2, and -3 protein production and messenger RNA expression in patients with vernal keratoconjunctivitis. Jpn J Ophthalmol 2009; 53:92-9. [PMID:19333691].
34. Fukagawa K, Nakajima T, Tsubota K, Shimmura S, Saito H, Hirai K. Presence of eotaxin in tears of patients with atopic keratoconjunctivitis with severe corneal damage. J Allergy Clin Immunol 1999; 103:1220-1. [PMID:10359913].
35. Eperon S, Sauty A, Lanz R, Leimgruber A, Lurati F, Guex-Crosier Y. Eotaxin-1 (CCL11) up-regulation in tears during seasonal allergic conjunctivitis. Graefes Arch Clin Exp Ophthalmol 2004; 242:966-70. [PMID:15221302].
36. Kumagai N, Fukuda K, Ishimura Y, Nishida T. Synergistic induction of eotaxin expression in human keratocytes by TNF-alpha and IL-4 or IL-13. Invest Ophthalmol Vis Sci 2000; 41:1448-53. [PMID:10798661].
37. Kumagai N, Fukuda K, Fujitsu Y, Nishida T. Synergistic effect of TNF-alpha and either IL-4 or IL-13 on VCAM-1 expression by cultured human corneal fibroblasts. Cornea 2003; 22:557-61. [PMID:12883351].